Target intelligence / Profile preview

Group A nerve fiber (Group A)

Target
Group A
Molecular classification
Other (classification of peripheral nerve fibers)
01

Overview

Group A nerve fibers are a category of heavily myelinated peripheral nerve axons classified according to diameter, conduction velocity, and function within both sensory and motor systems[1][2][3][5]. The group is subdivided into A-alpha (proprioceptive; largest, fastest), A-beta (mechanoreceptive, touch), A-gamma (motor to muscle spindle), and A-delta (nociceptive, cold, acute pain)[1][2][5]. These fibers support rapid transmission of electrical signals across the nervous system. They are primarily physiological units rather than single molecular targets, and are frequently referenced in the context of pain and neurophysiology. Their loss or dysfunction is implicated in diseases such as neuropathies and neurodegeneration, but they are not themselves a druggable target. Drugs such as local anesthetics inhibit their signal propagation by blocking sodium channels, resulting in nerve block for pain management or anesthesia[6][7].

Other names
A fibersA-alpha fiberA-beta fiberA-gamma fiberA-delta fiber
02

Mechanism of action

Blockade of sodium channels; Inhibition of action potential propagation

03

Biological functions

Sensory transmissionMotor transmissionPain signaling (A-delta subtype)Proprioception (A-alpha subtype)Mechanoreception (A-beta subtype)Muscle spindle regulation (A-gamma subtype)
04

Disease associations

Neuropathic painInflammationNeurodegenerative diseasePeripheral neuropathy
05

Safety considerations

Injury may result in loss of proprioception, muscle weakness, or acute pain deficitDemyelination (as in multiple sclerosis) leads to impaired conductionPeripheral neuropathy risk
06

Interacting drugs

Local anesthetics (e.g. lidocaine inhibits A-delta and A-gamma fibers)

1 more in the full profile.

07

Biomarkers

Electrophysiological nerve conduction studies (used to assess A fiber integrity)

Beyond the preview

Go deeper on Group A nerve fiber (Group A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Group A nerve fiber (Group A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call